These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2871678)

  • 1. [Effect of radiation sterilization on the immunobiological properties of the sorbed protective fraction of Bordetella pertussis].
    Bazhanova IG; Tsvetkova NV; Bulk VF; Mashilova GM; Lazareva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):78-82. PubMed ID: 2871678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunobiological properties of a corpuscular pertussis vaccine inactivated by gamma irradiation].
    Sanin AV; Sosnovskiĭ OIu; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (3):57-9. PubMed ID: 8771732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety and protective properties of a new cell-free pertussis vaccine in animal trials].
    Bazhanova IG; Remova TN; Ozeretskovskaia MN; Shmeleva EI; Mertsalova NU; Sukhinova EE; Chuprinina RP; Bulk VF; Semina IE; Koval'skaia SIa
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):40-5. PubMed ID: 8184612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of blastolysin on the development of specific immunity to whooping cough].
    Shepeleva IB; Zakharova NS; Remova TN; Bazhanova IG; Britsina MV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jan; (1):62-5. PubMed ID: 3705806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MH; Britsina MV; Shmeleva EI; Mertsalova NU; Ermolova EI; Sukhinova EE; Bulk VF; Sirotinskiĭ AV; Poluiianova AG; Sviridov VV; Vartanian IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):67-70. PubMed ID: 9304334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
    Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine].
    Zaĭtsev EM; Poddubikov AV; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Bazhanova IG; Plekhanova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):20-4. PubMed ID: 24738289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pathomorphologic study of the toxic properties of a corpuscular pertussis vaccine and of a cell-free pertussis preparation].
    Grigor'eva LV; Ozeretskovskaia MN; Chigirinskiĭ AE; Koval'skaia SIa; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):52-7. PubMed ID: 2555983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interrelation of the toxicity and capacity of pertussis vaccines to alter the body immune response to heterogenetic antigens].
    Levina LA; Elkina SI; Beĭlina VB; Prilepin NA; Kalina NG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):75-9. PubMed ID: 6282013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acellular pertussis vaccine].
    Zakharova NS; Britsina MV; Mertsalova NU; Bazhanova IG; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):35-41. PubMed ID: 18368750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.